University Hospital Duesseldorf

Düsseldorf 40225

1 studies enrolling now · 7 studies all time

What they study most

BRCA 1 Gene Mutation, BRCA 2 Gene Mutation, Breast Neoplasms, Chronic Graft-versus-host-disease, Essential Tremor, Hematological Diseases, Hemoglobinopathies, Multiple System Atrophy, Sickle Cell Disease, Upper Tract Urothelial Carcinomas, Urothelial Bladder Cancer

Studies at this site

• A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease — Recruiting now
• A Safety and Efficacy Study Evaluating CTX001 in Subjects With Severe Sickle Cell Disease — Completed
• A Study To Assess the Safety and Efficacy of JZP385 in the Treatment of Adults With Moderate to Severe Essential Tremor (ET) — Completed
• Oral Infigratinib for the Adjuvant Treatment of Subjects With Invasive Urothelial Carcinoma With Susceptible FGFR3 Genetic Alterations — Stopped early
• Study of BHV-3241 in Participants With Multiple System Atrophy — Completed
• A Study Evaluating Talazoparib (BMN 673), a PARP Inhibitor, in Advanced and/or Metastatic Breast Cancer Patients With BRCA Mutation (EMBRACA Study) — Completed
• A Phase 2, 2-Stage, 2-Cohort Study of Talazoparib (BMN 673), in Locally Advanced and/or Metastatic Breast Cancer Patients With BRCA Mutation (ABRAZO Study) — Stopped early